Navigation Links
Azathioprine Can Soon Revolutionize Eczema Treatment

Azathioprine, an immunosuppressant, meant for use in kidney transplant recipients can be used in treatment of eczema, a skin disorder. The drug was discovered 40 years ago, is still used to prevent the rejection of transplanted kidneys// in renal failure patients.

In around the 1960s, Roy Calne showed that azathioprine prevented the rejection of canine kidney transplants. Following this finding, a combination of azathioprine and corticosteroids were developed, for use in patents with transplanted kidneys.

Atopic eczema is a skin disorder that affects nearly 10-15% of children. Approximately one-third of these children carry the disease symptoms, into adulthood. High doses of topical steroid creams are given. This is however not a very effective form of treatment. The lack of a proper available treatment sparked interest among the researchers, in search of a more effective treatment.

Although, some Dermatologists believed that azathioprine could be useful in eczema treatment, no clinical trials had been initiated so far. Nearly 63 patients with atopic eczema, a most common form of the disease were taken up into a 3- month clinical trial.

All the study participants had undergone a variety of treatments, including radiation therapy with ultraviolet light. Surprisingly, treatment with azathioprine was found to cure the irritating skin condition. Although the drug can have serious side effects such as increased susceptibility to infections, it can be minimized by modulating the drug dosage depending on the ability of the patient to metabolize the drug.

'I'd tried everything so had no hesitation in taking part in the trial. At its worst, I'd been covered from head to toe in eczema sores. It was so painful it stopped me from sleeping at night and it affected what I would wear because I tried to cover it up as much as possible. My eczema disappeared within a couple of months. It was the first time I'd been clear of eczema since I was a child,' remarked Lindsay Dodds, one of the study participants.

This path-breaking research has been conducted by Dr Simon Meggitt, Dermatologist, Newcastle's Royal Victoria Infirmary, in association with Prof Nick Reynolds at Newcastle University. 'This kind of promising development illustrates why we are so dedicated to raising funds for research into eczema and related skin disorders that blight so many people's lives,' said Matthew Patey, British Skin Foundation.


'"/>




Related medicine news :

1. Skin cancer linked to usage of Drug Azathioprine in organ transplants
2. Azathioprine to Treat Eczema?
3. Azathioprine 50mg Pills Recalled By FDA And Roxane Labs
4. Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer
5. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
6. Heart Stem Cells Could Revolutionize Cardiac Disease Therapy
7. Monoclonal Anti-Body To Revolutionize Brain Cancer Treatment
8. Bio-Functional Garments That Could Revolutionize Fashion Industry
9. New Technique Could Revolutionize Melanoma Diagnosis and Treatment
10. Absorption Of Carbon Nanotube Measured In Worms Revolutionize Cancer Research
11. Terahertz Imaging Promises To Revolutionize Breast Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: